News Focus
News Focus
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

Re: biotech_researcher post# 16037

Friday, 10/28/2016 6:21:33 AM

Friday, October 28, 2016 6:21:33 AM

Post# of 20689
Positive for MNTA, IMO. Let AMGN deal with the litigation of ABBV's Humira patents (#msg-118781959). By the time MNTA's Humira FoB is approved for marketing, the IP situation may well be clarified.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”